0.2292
price down icon10.71%   -0.0275
after-market Handel nachbörslich: .23 0.0008 +0.35%
loading

Finanzdaten der Akari Therapeutics Plc Adr-Aktie (AKTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Selling, General, and Administrative
1.975
- - 3.048 1.709
Interest Income/Expense
0.10
- - - -
Operating Income/Loss
-7.404
- -3.525 -5.278 -2.927
Nonoperating Income/Loss
-0.084
- -0.18 1.506 0.032
Income/Loss From Continuing Operations Before Tax
295.15%
-7.488
-1.895 -3.705 -3.772 -2.895
Income/Loss From Continuing Operations After Tax
295.15%
-7.488
-1.895 -3.705 -3.772 -2.895
Net Income/Loss
237.73%
-6.40
-1.895 -3.705 -3.772 -2.895
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
65,326.24
- 54,588.28 4,976.08 24,386.01
Diluted Average Shares
65,326.24
- 54,588.28 4,976.08 24,386.01
Basic Earnings Per Share
-
- - - -
Diluted Earnings Per Share
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):